Skip to main content

Table 1 Demographic, clinical and virological parameters

From: Impaired human immunodeficiency virus type 1 replicative fitness in atypical viremic non-progressor individuals

Patient ID

Viremic non-progressors (VNP)

Typical progressors (TP)

Rapid progressor (RP)

VNP-1

VNP-2

VNP-3

TP-1

TP-2

TP-3

RP

Demographics

 Agea

44

50

42

40

43

38

30

 Sexb

M

M

M

M

M

M

M

 Race

Black

Caucasian

Black

Caucasian

Black

Black

Black

 Risk Factorc

MSM

Unknown

MSM

MSM

MSM

MSM

MSM

 Years HIV+d

14

17

10

14

15

12

5

 Follow up (months)e

84

37

123

35

19

31

18

CD4+ (cells/mm3)

 CD4+ countf

563

443

479

386

361

126

11

 Mean CD4+ countg

529

445

442

483

457

293

57

 Range CD4+ countg

372–711

316–608

280–814

220–789

361–645

126–511

11–124

 Slope CD4+ counth

−0.6

−0.7

−0.4

−9.6

−8.2

−13.1

−4.7

HIV-1 RNA (log 10 copies/ml)

 HIV-1 RNAf

5.46

4.90

4.70

4.41

4.27

4.49

4.64

 Mean HIV-1 RNAg

4.68

4.91

4.31

4.23

4.45

4.67

4.49

 Range HIV-1 RNAg

3.61–5.45

4.27–5.08

3.62–4.71

3.89–4.62

4.28–4.62

3.90–4.90

4.09–4.66

Virus characteristics

 HIV-1 subtypei

B

B

B

B

B

B

B

 HIV-1 coreceptor tropismj

R5

R5

R5

R5

R5

R5

D/M

  1. R5 CCR5-tropic virus, D/M dual- or mixed-tropic virus
  2. a Age at the time of sampling
  3. b M male
  4. c MSM men who have sex with men
  5. d Years since first HIV-seropositive test to time of blood sample collection for this study
  6. e Number of months that the patient had been monitored up to the blood sample collection date
  7. f CD4+ T-cell count (cells/mm3) and HIV-1 RNA plasma load (log10 copies/ml) at the time the blood sample was obtained
  8. g Mean and range CD4+ T-cell count and HIV-1 RNA plasma load values determined during the clinical follow up time, to the time of blood sample collection for this study and prior to the initiation of antiretroviral treatment
  9. h Rate of CD4+ T-cell count decline (slope) calculated as cells/mm3 per month, using all CD4+ cell measurements available at the time the blood sample was obtained
  10. i HIV-1 subtype determined using the near full-length HIV-1 genome consensus sequences with the Recombinant Identification Program (RIP) from the Los Alamos HIV Sequence Database (https://www.hiv.lanl.gov/content/sequence/RIP/RIP.html) [76]
  11. j HIV-1 coreceptor tropism determined using sequencing reads corresponding to the V3 region of gp120, env gene with the DEEPGENâ„¢HIV Software Tool Suite [70]